- Home
- BWAY vs LFVN Comparison
BWAY vs LFVN Comparison
Compare BWAY & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- LFVN
- Stock Information
- Founded
- BWAY 2003
- LFVN N/A
- Country
- BWAY Israel
- LFVN United States
- Employees
- BWAY N/A
- LFVN N/A
- Industry
- BWAY Medical/Dental Instruments
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- BWAY Health Care
- LFVN Health Care
- Exchange
- BWAY Nasdaq
- LFVN Nasdaq
- Market Cap
- BWAY 201.1M
- LFVN 165.9M
- IPO Year
- BWAY 2019
- LFVN N/A
- Fundamental
- Price
- BWAY $10.96
- LFVN $12.53
- Analyst Decision
- BWAY Strong Buy
- LFVN Strong Buy
- Analyst Count
- BWAY 2
- LFVN 2
- Target Price
- BWAY $14.25
- LFVN $30.50
- AVG Volume (30 Days)
- BWAY 33.7K
- LFVN 106.2K
- Earning Date
- BWAY 08-05-2025
- LFVN 05-06-2025
- Dividend Yield
- BWAY N/A
- LFVN 1.44%
- EPS Growth
- BWAY N/A
- LFVN 152.87
- EPS
- BWAY 0.08
- LFVN 0.70
- Revenue
- BWAY $43,457,000.00
- LFVN $222,347,000.00
- Revenue This Year
- BWAY $351.53
- LFVN $17.36
- Revenue Next Year
- BWAY $21.84
- LFVN $9.60
- P/E Ratio
- BWAY $54.48
- LFVN $17.88
- Revenue Growth
- BWAY 26.86
- LFVN 8.22
- 52 Week Low
- BWAY $5.67
- LFVN $5.22
- 52 Week High
- BWAY $12.00
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- BWAY 58.38
- LFVN 47.18
- Support Level
- BWAY $10.81
- LFVN $12.31
- Resistance Level
- BWAY $11.40
- LFVN $12.90
- Average True Range (ATR)
- BWAY 0.46
- LFVN 0.43
- MACD
- BWAY -0.03
- LFVN 0.02
- Stochastic Oscillator
- BWAY 50.88
- LFVN 33.67
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.